Last reviewed · How we verify
NCT04938921: TAPVC
Sutureless Closure for Primary Total Anomalous Pulmonary Venous Connection
trial in Total Anomalous Pulmonary Venous Connection in 30 participants. Status unknown.
1 June 2022
Quick facts
| Lead sponsor | Children's Hospital 1 |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 30 May 2019 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 June 2024 |
| Sites | 1 location across Vietnam |
Conditions studied
- Total Anomalous Pulmonary Venous Connection — all drugs for Total Anomalous Pulmonary Venous Connection →
- Pulmonary Venous Stenosis — all drugs for Pulmonary Venous Stenosis →
- Sutureless Closure — all drugs for Sutureless Closure →
Sponsor
Children's Hospital 1
Who can join
Under 15, any sex, with Total Anomalous Pulmonary Venous Connection or Pulmonary Venous Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to assess the percentage of pulmonary venous stenosis after TAPVC repair with sutureless closure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04938921
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Total Anomalous Pulmonary Venous Connection
Currently open trials in the same condition.
- NCT06768008 — An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Diseas · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04938921 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's Hospital 1
- Last refreshed: 25 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04938921.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing